SC, S., KA, P., K, R., D, T., MWA, K., P, M., . . . D, S. (2022). CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer. Molecular cancer, 21(1), 83. https://doi.org/10.1186/s12943-022-01565-1
Chicago Style (17th ed.) CitationSC, Selvakumar, Preethi KA, Ross K, Tusubira D, Khan MWA, Mani P, Rao TN, and Sekar D. "CRISPR/Cas9 and Next Generation Sequencing in the Personalized Treatment of Cancer." Molecular Cancer 21, no. 1 (2022): 83. https://doi.org/10.1186/s12943-022-01565-1.
MLA (9th ed.) CitationSC, Selvakumar, et al. "CRISPR/Cas9 and Next Generation Sequencing in the Personalized Treatment of Cancer." Molecular Cancer, vol. 21, no. 1, 2022, p. 83, https://doi.org/10.1186/s12943-022-01565-1.
Warning: These citations may not always be 100% accurate.